88IV - PR Newswire Asia's news - Medical/Pharmaceuticals


Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance Medison, the creator and leader of the multi-regional ... 2024-04-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update Delivered solid performance to start 2024, with record-breaking first quarter revenue of 34.1 billion KRW . Strong sales momentum continued from key products, funding investments in ongoing R&D programs. ... 2024-04-30T Banking/Financial Service Biotechnology Health Care/Hospital Medical/Pharmaceuticals
I-MAB Filed 2023 Annual Report on Form 20-F ROCKVILLE, Md. , April 30, 2024 /PRNewswire/ -- I-Mab (the "Company") (NASDAQ: IMAB), a U.S.-based, global biotech company, exclusively focused on the development and potential ... 2024-04-30T Banking/Financial Service Health Care/Hospital Medical/Pharmaceuticals
BiO-LiFE Herbalmeds Launches The Power of Sleep Campaign To Encourage Malaysians To Sleep Well and Stay Healthy Herbalmeds partners with Watsons Malaysia to launch a series of sleep-focused consumer engagement activities ... 2024-04-30T Health Care/Hospital Household/Consumer/Cosmetics Medical/Pharmaceuticals
BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report Three-part report investigates rapid pipeline growth, partnerships, clinical trials , and patient access challenges in cancer treatment ... 2024-04-30T Biotechnology Health Care/Hospital Medical/Pharmaceuticals Publishing/Information Service
111 to Announce First Quarter 2024 Unaudited Financial Results on May 23, 2024 - Conference Call to Follow SHANGHAI , April 30, 2024 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading tech-enabled healthcare platform company committed to digitally connecting ... 2024-04-30T Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Innovent Announces the Appointment of Dr. Samuel Zhang as Global Chief Business Officer (CBO) SAN FRANCISCO and SUZHOU, China , April 30, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures ... 2024-04-30T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
WuXi Biologics Releases 2023 ESG Report Demonstrating Strong Sustainability Commitment The Company demonstrated a deep commitment to achieving ESG success in partnership with global clients, creating long-term value for all stakeholders. The Company made remarkable progress in tackling ... 2024-04-30T Biotechnology Environmental Products & Services Health Care/Hospital Medical/Pharmaceuticals
Chang Gung Memorial Hospital, Linkou, Garners Two Prestigious International Awards for Its Outstanding Achievements The hospital honored with Hospital of the Year - Taiwan and Smart Hospital Initiative of the Year - Taiwan at the Healthcare Asia Awards ... 2024-04-30T Health Care/Hospital Medical/Pharmaceuticals
CARsgen Submitted Responses to FDA Observations SHANGHAI , April 29, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies ... 2024-04-29T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Medical/Pharmaceuticals